Literature DB >> 2933588

A late-differentiation antigen associated with the helper inducer function of human T cells.

N Suciu-Foca, E Reed, P Rubinstein, W MacKenzie, A K Ng, D W King.   

Abstract

T lymphocytes possessing helper function produce soluble factors that greatly augment B-cell proliferation and differentiation into antibody-secreting cells. In humans the subset of T lymphocytes bearing the T4 surface antigen comprises most of the cells that display helper activity and recognize class II antigens of the major histocompatibility complex (MHC), while the subset bearing the T8 antigen comprises T cells recognizing class I MHC antigens and exhibiting cytotoxic or suppressor function. Monoclonal antibodies to T4 or T8 greatly inhibit the cognitive and effector function of cells with the corresponding phenotype. This function/phenotype correlation is not absolute, however, for there are many examples of T8-positive clones that recognize MHC class II antigens and have helper activity, as well as of T4-positive clones with suppressor or cytotoxic function. Recently a family of cell-surface neoantigens, which might be relevant to T-cell function and which are present on activated but not on resting T lymphocytes, has been identified in mouse and humans using monoclonal antibodies. Some of these antibodies block the cytolytic activity of alloreactive T-cell clones, suggesting the possible involvement of such molecules in the activation of cytotoxic T-cell clones or in the lytic process itself. We now describe a similar late-differentiation antigen (LDA1) that is expressed by human T lymphocytes only following activation and is recognized by a monoclonal antibody that inhibits the antibody-inducing helper function of T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933588     DOI: 10.1038/318465a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  7 in total

1.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 2.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

Authors:  P E Harris; K Strba-Cechova; P Rubinstein; D Mann; D W King; N Suciu-Foca
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles.

Authors:  Pradeep Kumar Dagur; Gulnaz Tatlici; Mark Gourley; Leigh Samsel; Nalini Raghavachari; Poching Liu; Delong Liu; J Philip McCoy
Journal:  Cytometry B Clin Cytom       Date:  2010-03       Impact factor: 3.058

5.  Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance.

Authors:  D W King; E Reed; N Suciu-Foca
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.

Authors:  M Cebrián; E Yagüe; M Rincón; M López-Botet; M O de Landázuri; F Sánchez-Madrid
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  The isolation and sequence of a novel gene from a human functional T cell line.

Authors:  J Jongstra; T J Schall; B J Dyer; C Clayberger; J Jorgensen; M M Davis; A M Krensky
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.